Research & Development



  “小哲這孩子太善良不適合走仕途!”   “你看,富貴到了極限,財富跟權勢就能滿足我們每個人心底里最深沉的欲望。所以啊,我們的家業不敢丟掉了,一旦丟掉了,我這樣的人是沒法子過苦日子的。”2014彩票的发展   由于大隊人馬已經走到了南陽郡的境內,所以,大將軍衛青在第一時間就把前來迎接皇帝大駕的南陽郡守張吉斬首。2014彩票秘籍书   雲瑯笑了,劉徹無疑是在恫嚇他。   總之,劉徹在跟雲瑯,曹襄,霍去病一起打麻將的時候精神極度的飽滿,非常放得開。2013福利彩票开奖记录   曹襄搖頭道︰“問了也沒有實話。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo